title: Sunitinib-induced thyrotoxicosis.
authors.forename: D
authors.initials: D
authors.lastname: Piñar
authors.forename: E
authors.initials: E
authors.lastname: Boix
authors.forename: J A
authors.initials: JA
authors.lastname: Meana
authors.forename: J
authors.initials: J
authors.lastname: Herrero
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002231:Carbimazole / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D013963:Thyroid Hormones / Q000097:blood; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D013963:Thyroid Hormones; D002231:Carbimazole; D011433:Propranolol; D000077210:Sunitinib; D011241:Prednisone